These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 26546750)

  • 41. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test.
    Crotta S; Segnan N; Paganin S; Dagnes B; Rosset R; Senore C
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):633-8. PubMed ID: 22426085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching.
    Leuraud K; Jezewski-Serra D; Viguier J; Salines E
    Cancer Epidemiol; 2013 Dec; 37(6):959-67. PubMed ID: 24035240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
    Wieten E; de Klerk CM; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1392-1399.e5. PubMed ID: 30055170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals.
    Álvarez C; Andreu M; Castells A; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas Á; Carballo F; Morillas JD; Hernández C; Jover R; Sarasqueta C; Enriquéz-Navascués JM; Hernández V; Estévez P; Macenlle R; Sala T; Balaguer F; Pellisé M; Moreira L; Gil I; Peris A; González-Rubio F; Ferrández A; Poves C; Ponce M; Grau J; Serradesanferm A; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; Santander C; Díaz Tasende J; Herreros A; Cacho G; Barranco LE; Bessa X;
    Gastrointest Endosc; 2013 Aug; 78(2):333-341.e1. PubMed ID: 23623039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial.
    Stoop EM; de Haan MC; de Wijkerslooth TR; Bossuyt PM; van Ballegooijen M; Nio CY; van de Vijver MJ; Biermann K; Thomeer M; van Leerdam ME; Fockens P; Stoker J; Kuipers EJ; Dekker E
    Lancet Oncol; 2012 Jan; 13(1):55-64. PubMed ID: 22088831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
    Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average-risk individuals.
    Ng SC; Ching JY; Chan VC; Wong MC; Tang R; Wong S; Luk AK; Lam TY; Gao Q; Chan AW; Wu JC; Chan FK; Lau JY; Sung JJ
    Aliment Pharmacol Ther; 2015 Jan; 41(1):108-15. PubMed ID: 25339583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia.
    Imperiale TF; Glowinski EA; Lin-Cooper C; Ransohoff DF
    Am J Med; 2012 Dec; 125(12):1181-7. PubMed ID: 23062404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
    Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
    Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
    Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.
    Imperiale TF; Monahan PO; Stump TE; Glowinski EA; Ransohoff DF
    Ann Intern Med; 2015 Sep; 163(5):339-46. PubMed ID: 26259154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implementation of an organized colorectal cancer screening program through quantitative fecal immunochemical test followed by colonoscopy in an urban low-income community: Guidance and strategies.
    Ribeiro U; Safatle-Ribeiro AV; Sorbello M; Kishi PHR; Cohend DD; Mattar R; Castilho VLP; Goncalves EMDN; Kawaguti F; Marques CFS; Alves VAF; Nahas SC; Eluf-Neto J
    Clinics (Sao Paulo); 2023; 78():100278. PubMed ID: 37639912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Analysis of community colorectal cancer screening in 50-74 years old people in Guangzhou, 2015-2016].
    Li Y; Liu HZ; Liang YR; Lin GZ; Li K; Dong H; Xu H; Wang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):81-85. PubMed ID: 29374902
    [No Abstract]   [Full Text] [Related]  

  • 56. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
    Digby J; Fraser CG; Carey FA; Diament RH; Balsitis M; Steele RJ
    J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
    Webendörfer S; Riemann JF
    Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
    Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
    Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CT colonography for detection and characterisation of synchronous proximal colonic lesions in patients with stenosing colorectal cancer.
    Park SH; Lee JH; Lee SS; Kim JC; Yu CS; Kim HC; Ye BD; Kim MJ; Kim AY; Ha HK
    Gut; 2012 Dec; 61(12):1716-22. PubMed ID: 22115824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years.
    Strul H; Kariv R; Leshno M; Halak A; Jakubowicz M; Santo M; Umansky M; Shirin H; Degani Y; Revivo M; Halpern Z; Arber N
    Am J Gastroenterol; 2006 Feb; 101(2):255-62. PubMed ID: 16454827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.